Patents by Inventor Barry Edward Ayres, deceased

Barry Edward Ayres, deceased has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 2,6-Di (substitutedamino) purine ribonucleoside analogues and administration to treat respiratory inflammation
    Patent number: 5925624
    Abstract: The present invention relates to 2,6-diaminopurine-.beta.-D-ribofuranuronamide derivatives of the following formula (I). These compounds and their salts and solvates are useful as anti-inflammatory agents, particularly in the treatment of patients with inflammatory conditions who are susceptible to leukocyte-induced tissue damage.
    Type: Grant
    Filed: September 18, 1995
    Date of Patent: July 20, 1999
    Assignee: Glaxo Group Limited
    Inventors: Michael Gregson, Barry Edward Ayres, deceased, George Blanch Ewan, Frank Ellis, John Knight
  • 2-6-diaminopurine precursors
    Patent number: 5889178
    Abstract: The present invention relates to compounds of formula (IV): ##STR1## wherein R.sup.a and R.sup.b each represent a hydrogen atom or together form an alkylidene group.
    Type: Grant
    Filed: September 22, 1997
    Date of Patent: March 30, 1999
    Assignee: Glaxo Group Limited
    Inventors: Michael Gregson, Barry Edward Ayres, deceased, George Blanch Ewan, Frank Ellis, John Knight